Position in CSBR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$137,844
-$37,350 QoQ
Shares Held
23,973
-5.4% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 61%
Shared 39%
None 0%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. CSBR ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in CSBR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $137,844 | 23,973 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $175,194 | 25,354 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $153,588 | 23,702 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $165,123 | 22,405 | Shares | Sole | 2025-08-12 | |
| 2023-12-31 | $150,834 | 26,839 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $366,886 | 59,080 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $559,340 | 87,671 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $467,488 | 116,291 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $549,339 | 121,805 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $913,537 | 121,805 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $906,744 | 113,343 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $909,901 | 111,919 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $924,774 | 110,619 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,224,199 | 119,902 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,343,133 | 130,655 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,449,710 | 128,293 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,419,025 | 131,513 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,225,338 | 132,469 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,277,875 | 133,669 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $986,072 | 133,253 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||